Abstract
This study provides an overview of 13 years of experience of preimplantation genetic diagnosis (PGD) for Huntington's disease (HD) at three European PGD centres in Brussels, Maastricht and Strasbourg. Information on all 331 PGD intakes for HD, couples’ reproductive history, PGD approach, treatment cycles and outcomes between 1995 and 2008 were collected prospectively. Of 331 couples for intake, 68% requested direct testing and 32% exclusion testing (with a preponderance of French couples). At the time of PGD intake, 39% of women had experienced one or more pregnancies. A history of pregnancy termination after prenatal diagnosis was observed more frequently in the direct testing group (25%) than in the exclusion group (10%; P=0.0027). PGD workup was based on two approaches: (1) direct testing of the CAG-triplet repeat and (2) linkage analysis using intragenic or flanking microsatellite markers of the HTT gene. In total, 257 couples had started workup and 174 couples (70% direct testing, 30% exclusion testing) completed at least one PGD cycle. In total, 389 cycles continued to oocyte retrieval (OR). The delivery rates per OR were 19.8%, and per embryo transfer 24.8%, resulting in 77 deliveries and the birth of 90 children. We conclude that PGD is a valuable and safe reproductive option for HD carriers and couples at risk of transmitting HD.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bates G, Harper P, Jones L : Huntington's Disease. New York: Oxford University Press, 2002.
MacDonald ME, Ambrose CM, Duyao MP et al: HDCRG: a novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971–983.
Novak MJ, Tabrizi SJ : Huntington's disease. BMJ 2010; 340: c3109.
Roos RA : Huntington's disease: a clinical review. Orphanet J Rare Dis 2010; 5: 40.
Moutou C, Gardes N, Viville S : New tools for preimplantation genetic diagnosis of Huntington's disease and their clinical applications. Eur J Hum Genet 2004; 12: 1007–1014.
Sermon K, De Rijcke M, Lissens W et al: Preimplantation genetic diagnosis for Huntington's disease with exclusion testing. Eur J Hum Genet 2002; 10: 591–598.
Sermon K, Goossens V, Seneca S et al: Preimplantation diagnosis for Huntington's disease (HD): clinical application and analysis of the HD expansion in affected embryos. Prenat Diagn 1998; 18: 1427–1436.
Sermon K, Seneca S, De Rycke M et al: PGD in the lab for triplet repeat diseases - myotonic dystrophy, Huntington's disease and Fragile-X syndrome. Mol Cell Endocrinol 2001; 183 Suppl 1: S77–S85.
Harper PS, Sarfarazi M : Genetic prediction and family structure in Huntington's chorea. BMJ (Clin Res Ed) 1985; 290: 1929–1931.
Schulman JD, Black SH, Handyside A, Nance WE : Preimplantation genetic testing for Huntington disease and certain other dominantly inherited disorders. Clin Genet 1996; 49: 57–58.
Stern HJ, Harton GL, Sisson ME et al: Non-disclosing preimplantation genetic diagnosis for Huntington disease. Prenat Diagn 2002; 22: 503–507.
Braude PR, De Wert GM, Evers-Kiebooms G, Pettigrew RA, Geraedts JP : Non-disclosure preimplantation genetic diagnosis for Huntington's disease: practical and ethical dilemmas. Prenat Diagn 1998; 18: 1422–1426.
Evers-Kiebooms G, Zoeteweij M, Harper PS : Prenatal Testing for Late-Onset Neurogenetic Diseases. Oxford: BIOS Scientific Publishers Ltd, 2002.
Dreesen J, Drusedau M, Smeets H et al: Validation of preimplantation genetic diagnosis by PCR analysis: genotype comparison of the blastomere and corresponding embryo, implications for clinical practice. Mol Hum Reprod 2008; 14: 573–579.
Wilton L, Thornhill A, Traeger-Synodinos J, Sermon KD, Harper JC : The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod 2009; 24: 1221–1228.
Gianaroli L, Plachot M, van Kooij R et al: ESHRE guidelines for good practice in IVF laboratories. Committee of the Special Interest Group on Embryology of the European Society of Human Reproduction and Embryology. Hum Reprod 2000; 15: 2241–2246.
Thornhill AR, de Die-Smulders CE, Geraedts JP et al: ESHRE PGD consortium ‘best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)’. Hum Reprod 2005; 20: 35–48.
Vandervorst M, Liebaers I, Sermon K et al: Successful preimplantation genetic diagnosis is related to the number of available cumulus-oocyte complexes. Hum Reprod 1998; 13: 3169–3176.
Devroey P, Van Steirteghem A : A review of ten years experience of ICSI. Hum Reprod Update 2004; 10: 19–28.
De Vos A, Van Steirteghem A : Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat Diagn 2001; 21: 767–780.
Goossens V, De Rycke M, De Vos A et al: Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum Reprod 2008; 23: 481–492.
Van Landuyt L, De Vos A, Joris H, Verheyen G, Devroey P, Van Steirteghem A : Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure. Fertil Steril 2005; 83: 1397–1403.
Sermon K, Van Steirteghem A, Liebaers I : Preimplantation genetic diagnosis. Lancet 2004; 363: 1633–1641.
Zegers-Hochschild F, Adamson GD, de Mouzon J et al: The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Hum Reprod 2009; 24: 2683–2687.
Bonduelle M, Liebaers I, Deketelaere V et al: Neonatal data on a cohort of 2889 infants born after ICSI (1991–1999) and of 2995 infants born after IVF (1983–1999). Hum Reprod 2002; 17: 671–694.
Wet betreffende medisch begeleide voortplanting en de bestemming van de overtollige embryo's en gameten (Law concerning assisted reproduction and the handeling of surpluss embryos and gametes). Belgisch Staatsblad 2007; 38575–38586.
Regeling van de staatssecretaris van Volksgezondheid, Welzijn en Sport van 16 februari 2009, nr. CZ-TSZ-2912089, houdende regels ten aanzien van preïmplantatie genetische diagnostiek (PGD) (Regeling preïmplantatie genetische diagnostiek) (Regulations of the State Secretary of Health on the rules concerning PGD). Staatscourant 2009; 1–12.
Conneally PM : Huntington disease: genetics and epidemiology. Am J Hum Genet 1984; 36: 506–526.
Decruyenaere M, Evers-Kiebooms G, Boogaerts A et al: The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation. Eur J Hum Genet 2007; 15: 453–462.
Harper JC, Coonen E, De Rycke M et al: ESHRE PGD consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October 2008. Hum Reprod 2010; 25: 2685–2707.
Jasper MJ, Hu DG, Liebelt J et al: Singleton births after routine preimplantation genetic diagnosis using exclusion testing (D4S43 and D4S126) for Huntington's disease. Fertil Steril 2006; 85: 597–602.
Tassicker RJ, Marshall PK, Liebeck TA, Keville MA, Singaram BM, Richards FH : Predictive and prenatal testing for Huntington Disease in Australia: results and challenges encountered during a 10-year period (1994–2003). Clin Genet 2006; 70: 480–489.
Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K : Genetic testing in asymptomatic minors: background considerations towards ESHG recommendations. Eur J Hum Genet 2009; 17: 711–719.
Simpson SA, Zoeteweij MW, Nys K et al: Prenatal testing for Huntington's disease: a European collaborative study. Eur J Hum Genet 2002; 10: 689–693.
Craufurd D, Dodge A, Kerzin-Storrar L, Harris R : Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 1989; 2: 603–605.
Creighton S, Almqvist EW, MacGregor D et al: Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clin Genet 2003; 63: 462–475.
Evers-Kiebooms G, Nys K, Harper P et al: Predictive DNA-testing for Huntington's disease and reproductive decision making: a European collaborative study. Eur J Hum Genet 2002; 10: 167–176.
Harper PS, Lim C, Craufurd D : Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's disease prediction consortium. J Med Genet 2000; 37: 567–571.
Maat-Kievit A, Vegter-van der Vlis M, Zoeteweij M, Losekoot M, van Haeringen A, Roos R : Paradox of a better test for Huntington's disease. J Neurol Neurosurg Psychiatry 2000; 69: 579–583.
Adam S, Wiggins S, Whyte P et al: Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment. J Med Genet 1993; 30: 549–556.
Maat-Kievit A, Vegter-van der Vlis M, Zoeteweij M et al: Experience in prenatal testing for Huntington's disease in the Netherlands: procedures, results and guidelines (1987–1997). Prenat Diagn 1999; 19: 450–457.
Tassicker RJ, Teltscher B, Trembath MK et al: Problems assessing uptake of Huntington disease predictive testing and a proposed solution. Eur J Hum Genet 2009; 17: 66–70.
van Rij MC, Gielen M, Lulofs R et al: Profiles and motives for PGD: a prospective cohort study of couples referred for PGD in the Netherlands. Hum Reprod 2011; 26: 1826–1835.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on European Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Van Rij, M., De Rademaeker, M., Moutou, C. et al. Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres. Eur J Hum Genet 20, 368–375 (2012). https://doi.org/10.1038/ejhg.2011.202
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2011.202
Keywords
This article is cited by
-
Genetic counseling and testing practices for late-onset neurodegenerative disease: a systematic review
Journal of Neurology (2022)
-
Live births following preimplantation genetic testing for dynamic mutation diseases by karyomapping: a report of three cases
Journal of Assisted Reproduction and Genetics (2020)
-
Single Circulating Fetal Trophoblastic Cells Eligible for Non Invasive Prenatal Diagnosis: the Exception Rather than the Rule
Scientific Reports (2020)
-
Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers
Journal of Genetic Counseling (2018)
-
Prenatal testing in Huntington disease: after the test, choices recommence
European Journal of Human Genetics (2016)
